FRET Profiling of Antibody Dynamics Under TIPS Factor Suppression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing technologies have limited understanding of tumor-induced or -produced factors (TIPS factors) that suppress humoral immune responses, leading to reduced efficacy of therapeutic antibodies, and there is a need for tools to analyze and counter their negative effects.
Innovation Solution
A kit and methods utilizing fluorescence resonance energy transfer (FRET) with fluor-labeled proteins or aptamers that bind specifically to the Fab and Fc domains of antibodies to characterize their structure and interaction with TIPS factors, allowing for the identification of substances that mitigate these suppressive effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If TIPS factors bind to antibodies, then antibody structure is altered and humoral immune response is suppressed, but therapeutic antibody efficacy is reduced
Solution Approach 1:
The patent uses FRET (fluorescence resonance energy transfer) as an intermediary detection mechanism to monitor antibody-TIPS factor interactions. By labeling antibodies with fluorescent donors and TIPS factors with acceptors, the system detects energy transfer that indicates binding, allowing identification of substances that mitigate TIPS factor effects without directly interfering with the antibody-TIPS interaction itself
Solution Approach 2:
The patent employs changes in fluorescence emission parameters (intensity, wavelength) to detect and quantify TIPS factor binding to antibodies. By monitoring these optical parameter changes, the system can identify substances that restore antibody function by preventing or reversing TIPS factor-induced structural alterations
2Measurement precision
If conventional assays are used to detect TIPS factors, then their levels can be monitored, but the mechanism of immune suppression and antibody dynamics cannot be characterized
Solution Approach 1:
The patent replaces conventional mechanical/chemical assay methods with an optical detection system based on FRET. This substitution allows simultaneous measurement of TIPS factor levels and real-time monitoring of antibody structural dynamics, preserving information about binding mechanisms and conformational changes that conventional assays cannot detect
Solution Approach 2:
The patent utilizes fluorescence color/wavelength changes as indicators of molecular interactions. The donor fluorophore emission intensity decreases while acceptor emission increases upon energy transfer, providing visual and quantitative information about antibody-TIPS factor binding and the effect of potential mitigating substances
3Loss of information
If FRET-based characterization is implemented, then antibody dynamics and TIPS factor interactions can be analyzed, but device complexity increases
Solution Approach 1:
The FRET-based assay system is designed to perform multiple functions simultaneously: detecting TIPS factor levels, monitoring antibody conformational changes, identifying binding mechanisms, and screening for mitigating substances. This multi-functionality consolidates what would otherwise require multiple separate assays into a single integrated platform
Solution Approach 2:
The antibody molecules themselves serve as the detection platform through their intrinsic ability to bind TIPS factors and undergo conformational changes. The fluorescent labels attached to antibodies and TIPS factors enable self-reporting of interaction events without requiring external detection machinery, simplifying the overall system architecture
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the characterization of antibody dynamics and identification of substances that enhance antibody efficacy by detecting changes in antibody structure induced by TIPS factors, thereby improving therapeutic outcomes.
Implementation Method 1
The first fluor and the second fluor participate in fluorescence resonance energy transfer (FRET) when bound to the antibody
Data Source
AI summary
Using protein structural probes one can identify tumor-induced or -produced (TIPS) factors that bind to therapeutic antibodies and change their dynamic structure, thereby negatively affecting their humoral immune functions as well as their pharmacologic activity. Using such protein structural probes and TIPS factors one can screen and identify inhibitors that can counter the binding of TIPS factors to affected therapeutic antibodies. These inhibitors can be used in the presence of a TIPS factor-susceptible antibody (TSA) for treating cancer. An inhibitor can be used alone or in combination with chemotherapy for treating cancer. Patients can be screened to identify those with low or no TIPS factor production as candidates for antibody therapy even in the case in which the antibody is a TSA. Conversely, those with high TIPS factor production are candidates for inhibitor therapy.